Administrative Core for Institution # 269291
机构行政核心
基本信息
- 批准号:10475406
- 负责人:
- 金额:$ 25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-05 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:AccountabilityAcquired Immunodeficiency SyndromeAffectAreaAssessment toolAwardBasic ScienceBiological AssayBiometryCatalogingCatalogsCell LineCellsCellular AssayCentral Nervous System Viral DiseasesCitiesClinicClinicalCollaborationsCollectionCommunicable DiseasesCommunicationCommunitiesCountryDataData AnalysesData CollectionDevelopmentEducational workshopEnsureEvaluationFosteringFundingGenesGoalsGrantHIVHIV-1ImpairmentIndividualInfrastructureInstitutesInstitutionInternationalLaboratory ResearchLeadershipLearningMeasuresMedicineMental disordersMentorshipMicroelectrodesMissionNational Institute of Mental HealthNeurologyNeuronsNeurosciencesOffice of Administrative ManagementOutcomeParticipantPerformancePersonsPhiladelphiaPhysiciansPlayProceduresProcessProductivityReportingResearchResearch PersonnelResearch SupportResourcesRoleScientistSeedsSelf AssessmentSeriesSocietiesSourceSpecimenStrategic PlanningStressTimeUnited States National Institutes of HealthUniversitiesUpdateViralVirusbasecell behaviorcohesioncohortcollegecommunity partnershipgenetic analysisgraduate studentimprovedinduced pluripotent stem cellinterestmicroscopic imagingnervous system disorderneuroAIDSneurobehavioraloperationpatient populationprogramsrecruitresponsestem cellssymposiumsynergismtool
项目摘要
SUMMARY
The main objective of the Central Administrative and Management Core (CAMC) is to serve as the anchor and
to provide administrative oversight for the Comprehensive NeuroHIV Center (CNHC) at Temple University and
Drexel University in Philadelphia. The overall objective is to improve and expand research related to neuroHIV
and neurological diseases associated with viral infection of the CNS including neurobehavioral impairment and
mental disorders. The infrastructure created by the CNHC during the last 10 years offers unique expertise to
local, regional, and national neuroHIV investigators with focus on our strengths of gene editing and delivery,
mammalian progenitor cells and iPSC cultures, assist investigators with genetic analysis of virus-infected cells
before and after editing procedures, and support for a full-range of state-of-the-art microscopic and imaging
analysis. At the same time, the CNHC will coordinate the NeuroHIV Community Partnership and Disparity Core
affecting PWH, the newly developed core that is now included in our program. The CAMC will assist with liaising
with current and potential community partners in fostering synergy among the patient population and the
participant researchers. Tkhe Center offers its unique expertise in functional cellular assays including
microelectrode array assay to study neuronal cell behavior in response to external stress. Furthermore, the
Center will enable investigators to initiate clinical and neurobehavioral examination with a well-established cohort
of people with HIV (PWH) longitudinally examined at Drexel University College of Medicine. The CAMC will
provide the infrastructure for coordinating and overseeing all activities of the CNHC and facilitating synergistic
interaction among the cores and other NIMH-supported Centers. The CAMC will delineate the strategic plan,
identify short- and long-term objectives, execute detailed plans to be implemented, carry out internal and external
reviews and assessment tools based on established criteria to ensure productive and efficient use of resources
to achieve the overall objectives of the CNHC. It will also offer biostatistical support for data analysis and
interpretation obtained from the basic science and clinical cores. In addition, this Core will coordinate with the
Scientific Cores to disseminate information to the participants as well as Core users, recruit Core users, solicitate
pilot applications, catalogue all original data generated by the Cores, facilitate and track all material distributed
by the Cores, including, but not limited to, cell lines, viral stocks, and clinical specimens.
总结
中央行政和管理核心(CAMC)的主要目标是充当锚和
为坦普尔大学综合神经艾滋病中心(CNHC)提供行政监督,
费城的德雷克塞尔大学。总体目标是改善和扩大与神经艾滋病毒有关的研究
和与CNS病毒感染相关的神经系统疾病,包括神经行为损伤,
精神障碍CNHC在过去10年中创建的基础设施提供了独特的专业知识,
地方,地区和国家的神经HIV研究人员,重点是我们的基因编辑和交付的优势,
哺乳动物祖细胞和iPSC培养物,协助研究人员对病毒感染的细胞进行遗传分析
前后编辑程序,并支持全方位的最先进的显微镜和成像
分析.同时,CNHC将协调NeuroHIV社区伙伴关系和差异核心
影响PWH,新开发的核心,现在包括在我们的计划。CAMC将协助联络
与当前和潜在的社区合作伙伴,促进患者群体和
参与研究者。Tkhe中心在功能性细胞分析方面拥有独特的专业知识,包括
微电极阵列测定以研究神经元细胞响应于外部应力的行为。而且
中心将使研究者能够对一个成熟的队列进行临床和神经行为检查
德雷克塞尔大学医学院对艾滋病毒(PWH)感染者进行了纵向检查。CAMC将
为协调和监督CNHC的所有活动提供基础设施,
核心和其他NIMH支持的中心之间的互动。CAMC将制定战略计划,
确定短期和长期目标,执行详细的实施计划,开展内部和外部
基于既定标准的审查和评估工具,以确保富有成效和高效地利用资源
实现CNHC的总体目标。它还将为数据分析提供生物统计支持,
从基础科学和临床核心中获得的解释。此外,该核心将与
科学核心向参与者和核心用户传播信息,招募核心用户,
试点应用程序,对核心产生的所有原始数据进行编目,促进和跟踪分发的所有材料
包括但不限于细胞系、病毒库和临床标本。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(13)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kamel Khalili其他文献
Kamel Khalili的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kamel Khalili', 18)}}的其他基金
HIV modulation of BAG3 impacting quality control of Tau in neuronal cells
HIV 对 BAG3 的调节影响神经元细胞中 Tau 的质量控制
- 批准号:
10170194 - 财政年份:2018
- 资助金额:
$ 25万 - 项目类别:
HIV modulation of BAG3 impacting quality control of Tau in neuronal cells
HIV 对 BAG3 的调节影响神经元细胞中 Tau 的质量控制
- 批准号:
10437950 - 财政年份:2018
- 资助金额:
$ 25万 - 项目类别:
HIV modulation of BAG3 impacting quality control of Tau in neuronal cells
HIV 对 BAG3 的调节影响神经元细胞中 Tau 的质量控制
- 批准号:
9922215 - 财政年份:2018
- 资助金额:
$ 25万 - 项目类别:
Nanotechnology Based Gene Editing to Eradicate HIV Brain Reservoir in Drug Abusers
基于纳米技术的基因编辑可根除吸毒者体内的艾滋病毒脑库
- 批准号:
9318489 - 财政年份:2016
- 资助金额:
$ 25万 - 项目类别:
Viral Gene Editing and Bioinformatics Core for Institution # 269291
机构病毒基因编辑和生物信息学核心
- 批准号:
10475410 - 财政年份:2011
- 资助金额:
$ 25万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 25万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 25万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 25万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 25万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 25万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 25万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 25万 - 项目类别:














{{item.name}}会员




